Related Experiment Video

Updated: Jul 19, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

[Polarization and immune regulation of TH cells in children with bronchial asthma]

Yu-Hong Jiang1, Ya-Qiu Wang, Kuan-Zhou Sun

  • 1Women and Children's Medical Center of Qingdao, Qingdao, Shandong 266011, China. jyh05832@sohu.com

Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics
|October 21, 2006
PubMed

Insights

This study found that children with bronchial asthma have lower levels of IL-2 and IFN-gamma, and a reduced percentage of TH1 cells, indicating altered immune cell polarization and potentially impaired cellular immunity in asthma.

Area of Science:

  • Immunology
  • Cellular Biology
  • Pediatric Medicine

Context:

  • Bronchial asthma is a chronic inflammatory airway disease.
  • T helper (TH) cell polarization plays a critical role in immune regulation.
  • Understanding TH cell subsets in pediatric asthma is crucial for developing targeted therapies.

Purpose:

  • To investigate the polarization and immune regulation of TH cells in children with bronchial asthma.
  • To compare serum levels of Interleukin-2 (IL-2) and Interferon-gamma (IFN-gamma) between asthmatic children and healthy controls.
  • To quantify the percentages of TH1 and TH2 cells in asthmatic and control groups.

Summary:

  • Asthmatic children exhibited significantly lower serum levels of IL-2 and IFN-gamma compared to healthy controls.
  • The percentage of TH1 cells was significantly decreased in asthmatic patients, while TH2 cells were increased.
  • These findings suggest abnormal TH1/TH2 cell polarization and potentially inhibited cellular immune function in pediatric bronchial asthma.

Impact:

  • Provides insights into the immunological mechanisms underlying bronchial asthma in children.
  • Highlights potential biomarkers (IL-2, IFN-gamma, TH1/TH2 ratio) for asthma assessment.
  • Suggests that therapeutic strategies targeting T helper cell balance may be beneficial for asthma management.
Abstract

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...